Inventor · name-matched record
ZHU RUI
5 granted patents·4 pending applications·0 citations·filing 2019–2025
58Inventor score
Files withARROWHEAD PHARMACEUTICALS INC3ADARX PHARMACEUTICALS INC2HUAWEI CLOUD COMPUTING TECH CO LTD1SCIWIND BIOSCIENCES USA CO LTD1STANFORD RES INST INT1
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
9 records- 0185US2026043025A1RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)ARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0261US2026042854A1Anti-glp-1r antibodies and uses thereofSCIWIND BIOSCIENCES USA CO LTD·Filed 2023·Application pending·0 cites
- 0359US2026000775A1a4ß1/7 INTEGRIN LIGAND CONJUGATED COMPOUNDS AND USES THEREOFADARX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0458US2026003098A1Porosity and permeability model method and system for delta front channel based on spatial trend constraintUNIV YANGTZE·Filed 2024·Application pending·0 cites
- 0550US12595477B2Complement Factor B-modulating compositions and methods of use thereofADARX PHARMACEUTICALS INC·Filed 2022·Granted Apr 7, 2026·0 cites·19 claims
- 0649US12581757B2Multiresolution imager for night visionSTANFORD RES INST INT·Filed 2020·Granted Mar 17, 2026·0 cites·17 claims
- 0748US12582668B2Methods for the treatment of alpha-1 antitrypsin deficiency (AATD)ARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Mar 24, 2026·0 cites·22 claims
- 0848US12534728B2RNAi agents for inhibiting expression of 17beta-HSD type 13 (HSD17B13), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Jan 27, 2026·0 cites·45 claims
- 0946US12572842B2Methods and systems for decentralized federated learningHUAWEI CLOUD COMPUTING TECH CO LTD·Filed 2020·Granted Mar 10, 2026·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when ZHU RUI files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →